184 related articles for article (PubMed ID: 23217722)
1. [Definitions related to pharmacovigilance and drug safety].
Möller H; Aly AF
Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):709-11. PubMed ID: 23217722
[TBL] [Abstract][Full Text] [Related]
2. [Plan of action for improving medicinal drug safety].
Sommer H; Dwenger A
Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):707-8. PubMed ID: 23217721
[No Abstract] [Full Text] [Related]
3. [Drug safety research].
Aly AF; Möller H
Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):729-32. PubMed ID: 23217726
[TBL] [Abstract][Full Text] [Related]
4. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
5. Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention.
Goedecke T; Ord K; Newbould V; Brosch S; Arlett P
Drug Saf; 2016 Jun; 39(6):491-500. PubMed ID: 26940903
[TBL] [Abstract][Full Text] [Related]
6. Terms used in patient safety related to medication: a literature review.
Pintor-Mármol A; Baena MI; Fajardo PC; Sabater-Hernández D; Sáez-Benito L; García-Cárdenas MV; Fikri-Benbrahim N; Azpilicueta I; Faus MJ
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):799-809. PubMed ID: 22678709
[TBL] [Abstract][Full Text] [Related]
7. The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population.
Lam MP; Cheung BM
Expert Rev Clin Pharmacol; 2012 Mar; 5(2):187-97. PubMed ID: 22390561
[TBL] [Abstract][Full Text] [Related]
8. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
9. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
Gotta V; van den Anker J; Pfister M
Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
[TBL] [Abstract][Full Text] [Related]
10. [Medication safety in nursing homes].
Jaehde U; Thürmann PA
Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):712-6. PubMed ID: 23217723
[TBL] [Abstract][Full Text] [Related]
11. [European drug agency and drug management].
Barfuss W
Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
[No Abstract] [Full Text] [Related]
12. [Process related risk of drug therapy: trust is good - control is better].
Grandt D; Aly AF
Z Evid Fortbild Qual Gesundhwes; 2012; 106(10):705-6. PubMed ID: 23217720
[No Abstract] [Full Text] [Related]
13. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
Awada Z; Zgheib NK
Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate medications and adverse drug reactions in the elderly.
Gallagher P; O'Mahony D
Clin Pharmacol Ther; 2009 May; 85(5):472; author reply 472-3. PubMed ID: 19212315
[No Abstract] [Full Text] [Related]
15. Is there a need for forensic pharmacovigilance as a specialty?
Body D; Edwards IR; Hartigan Go K; Healy D; Herxheimer A; Labadie J
Int J Risk Saf Med; 2011; 23(1):31-42. PubMed ID: 21507784
[No Abstract] [Full Text] [Related]
16. Medical errors challenges for the health professionals: need of Pharmacovigilance to prevent.
Das BP; Rauniar GP; Bhattacharya SK
JNMA J Nepal Med Assoc; 2006; 45(162):273-8. PubMed ID: 18365356
[TBL] [Abstract][Full Text] [Related]
17. [Adverse drug effects on the eye].
Schlote T; Kellner U
Klin Monbl Augenheilkd; 2009 Nov; 226(11):R173-86. PubMed ID: 20166243
[No Abstract] [Full Text] [Related]
18. [Drug observatories to make practices safer].
Lanoue MC
Soins; 2014 Apr; (784):40-2. PubMed ID: 24839684
[TBL] [Abstract][Full Text] [Related]
19. [Adverse drug effects in the community pharmacy].
Arnet I; Seidling HM; Hersberger KE
Ther Umsch; 2015 Dec; 72(11-12):687-92. PubMed ID: 26654812
[TBL] [Abstract][Full Text] [Related]
20. [Problems of drug therapy in pediatrics].
Wimmer S; Rascher W
Kinderkrankenschwester; 2016 Jan; 35(1):5-10. PubMed ID: 26934799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
